DE69129395D1 - Antimikrobielle Peptide - Google Patents

Antimikrobielle Peptide

Info

Publication number
DE69129395D1
DE69129395D1 DE69129395T DE69129395T DE69129395D1 DE 69129395 D1 DE69129395 D1 DE 69129395D1 DE 69129395 T DE69129395 T DE 69129395T DE 69129395 T DE69129395 T DE 69129395T DE 69129395 D1 DE69129395 D1 DE 69129395D1
Authority
DE
Germany
Prior art keywords
antimicrobial peptides
antimicrobial
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69129395T
Other languages
English (en)
Other versions
DE69129395T2 (de
Inventor
Mamoru Tomita
Kohzo Kawasa
Mitsunori Takase
Wayne Robert Bellamy
Kohoji Yamauchi
Hiroyuki Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Application granted granted Critical
Publication of DE69129395D1 publication Critical patent/DE69129395D1/de
Publication of DE69129395T2 publication Critical patent/DE69129395T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69129395T 1990-09-07 1991-09-06 Antimikrobielle Peptide Expired - Lifetime DE69129395T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23836490 1990-09-07
JP3186260A JP2818056B2 (ja) 1990-09-07 1991-07-25 抗菌性ペプチドおよび抗菌剤

Publications (2)

Publication Number Publication Date
DE69129395D1 true DE69129395D1 (de) 1998-06-18
DE69129395T2 DE69129395T2 (de) 1998-12-17

Family

ID=26503644

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129395T Expired - Lifetime DE69129395T2 (de) 1990-09-07 1991-09-06 Antimikrobielle Peptide

Country Status (8)

Country Link
US (1) US5304633A (de)
EP (1) EP0474506B1 (de)
JP (1) JP2818056B2 (de)
AU (1) AU645342B2 (de)
CA (1) CA2050786C (de)
DE (1) DE69129395T2 (de)
DK (1) DK0474506T3 (de)
NZ (1) NZ239683A (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5553455A (en) * 1987-12-21 1996-09-10 United Technologies Corporation Hybrid ceramic article
US5849881A (en) * 1989-05-05 1998-12-15 Baylor College Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
US5766939A (en) * 1989-05-05 1998-06-16 Baylor College Of Medicine Production of recombinant lactoferrin and lactoferrin polypeptides using CDNA sequences in various organisms
AU659440B2 (en) * 1991-03-13 1995-05-18 Morinaga Milk Industry Company Limited Antimicrobial peptide and an antimicrobial agent
EP0503939B1 (de) * 1991-03-13 1997-06-18 Morinaga Milk Industry Co., Ltd. Antimikrobielles Peptid und antimikrobieller Wirkstoff
DK0510912T3 (da) * 1991-04-24 1998-02-09 Morinaga Milk Industry Co Ltd Antimikrobielt peptid og antimikrobielt middel
JP3110078B2 (ja) * 1991-06-21 2000-11-20 森永乳業株式会社 高純度抗菌性ペプチドの大量製造法
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5646119A (en) * 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
US5912230A (en) * 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
US5631228A (en) * 1991-11-01 1997-05-20 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
JP3207535B2 (ja) * 1992-08-07 2001-09-10 森永乳業株式会社 抗酸化剤
JP3312946B2 (ja) * 1993-03-04 2002-08-12 雪印乳業株式会社 ウイルス感染・増殖抑制剤
JP3529423B2 (ja) * 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
US5712247A (en) * 1995-02-21 1998-01-27 University Of North Carolina Use of lactoferrin to modulate and/or neutralize heparin activity
AU5386996A (en) * 1995-04-05 1996-10-23 Picower Institute For Medical Research, The Agents for binding to advanced glycosylation endproducts, an d methods of their use
US5962245A (en) * 1995-04-05 1999-10-05 The Picower Institute For Medical Research Methods for detecting the presence of advanced glycosylation endproducts
FR2735983B1 (fr) 1995-06-29 1997-12-05 Centre Nat Rech Scient Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
JP3556757B2 (ja) * 1996-02-09 2004-08-25 森永乳業株式会社 吸収促進性糖類組成物
US5994308A (en) 1996-02-28 1999-11-30 Board Of Trustees Of Southern Illinois University Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use
US6111081A (en) * 1996-05-31 2000-08-29 Baylor College Of Medicine Lactoferrin variants and uses thereof
BR9713166A (pt) * 1996-08-14 2000-02-01 Novartis Ag Peptideo com atividade inibidora para fungos patogênicos de plantas
US6531573B1 (en) 1997-12-18 2003-03-11 Trustees Of Boston University Antifungal and antibacterial peptides
CA2294018A1 (en) * 1998-04-13 1999-10-21 New England Medical Center Hospitals, Inc. Methods and compositions for inactivating infectious agents using lactoferrin and related molecules
AU761477B2 (en) 1998-06-17 2003-06-05 New Zealand Dairy Board Bioactive whey protein hydrolysate
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
JP2002204681A (ja) * 1998-08-12 2002-07-23 Morinaga Milk Ind Co Ltd 生鮮食品保存用氷
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
US7115557B2 (en) * 1998-09-25 2006-10-03 Sciaticon Ab Use of certain drugs for treating nerve root injury
SE9803710L (sv) * 1998-09-25 2000-03-26 A & Science Invest Ab Användning av vissa substanser för behandling av nervrotsskador
US7906481B2 (en) * 1998-09-25 2011-03-15 Sciaticon Ab Specific TNF-A inhibitors for treating spinal disorders mediated by nucleous pulposus
US7811990B2 (en) * 1998-09-25 2010-10-12 Sciaticon Ab Soluble cytokine receptors TNF-α blocking antibodies for treating spinal disorders mediated by nucleus pulposus
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
US6998259B1 (en) 1999-05-20 2006-02-14 Davisco Foods International Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
US6630320B1 (en) 2000-05-08 2003-10-07 Devisco Foods International, Inc. Treatment of hypertension in mammals with hydrolyzed whey proteins
US7060677B1 (en) 1999-11-11 2006-06-13 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
JP3597491B2 (ja) * 2001-06-27 2004-12-08 株式会社ティーセル研究所 泌乳牛における乳腺の免疫賦活化剤および賦活化方法
US8778889B2 (en) * 2003-03-10 2014-07-15 The United States Of America As Represented By The Secretary Of The Army Antimicrobial decapeptide oral hygiene treatment
US20040259770A1 (en) * 2003-06-19 2004-12-23 Rush University Medical Center Method for determining leukocyte activation
NZ544448A (en) * 2004-03-19 2009-10-30 Morinaga Milk Industry Co Ltd Medicine for cancer therapy containing a lactoferrin hydrolysate and antibody
WO2006047744A2 (en) * 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
US20070231833A1 (en) * 2005-05-23 2007-10-04 Arcidiacono Steven M Labeled antimicrobial peptides and method of using the same to detect microorganisms of interest
DE602006020617D1 (de) 2005-12-30 2011-04-21 Evonik Roehm Gmbh Lactoferrin-peptide, geeignet als in die zelle eindringende peptide
WO2008006117A2 (en) * 2006-07-07 2008-01-10 Bioassets Development Corporation Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures
EP2050461A1 (de) * 2007-10-19 2009-04-22 PharmaSurgics in Sweden AB Peptide basierend auf der menschlichen Lactoferrinsequenz und ihre Verwendung
EP2060586A1 (de) * 2007-11-14 2009-05-20 PharmaSurgics in Sweden AB Neue synthetische Arginin-substituierte Peptide und ihre Verwendung
EP2387390B1 (de) * 2009-01-13 2012-11-28 PharmaSurgics in Sweden AB Hyaluronsäure enthaltende zusammensetzungen zur behandlung von wunden, narben und postoperativer adhäsionsbildung
EP2481751A1 (de) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Humanem Lactoferrin abgeleitete Peptide
WO2012131599A1 (en) * 2011-03-29 2012-10-04 Scms Institute Of Bioscience And Biotechnology Research And Development Sequences, transgenic products and processes thereof
JP5537578B2 (ja) * 2011-04-28 2014-07-02 森永乳業株式会社 ラクトフェリン加水分解物の製造方法
JP5894457B2 (ja) * 2012-02-22 2016-03-30 株式会社Adeka ペプチド含有抗菌性組成物
JP2015224327A (ja) * 2014-05-29 2015-12-14 花王株式会社 繊維製品用洗浄剤組成物
ITUB20153058A1 (it) 2015-08-11 2017-02-11 Farmagens Health Care S R L Roma ?frammento di lattoferrina per uso come agente antibatterico ed antivirale?
CN111087449B (zh) * 2019-12-31 2021-05-14 金陵科技学院 一种抗菌肽及其制备方法与应用
CN113201066B (zh) * 2020-12-24 2021-12-03 四川大学 基于乳铁蛋白的仿生抗菌功能多肽及制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986004217A2 (en) * 1985-01-18 1986-07-31 Kailash Kumar Gauri Protein hydrolysates, production process and drugs containing th em
JPH0725B2 (ja) * 1986-08-25 1995-01-11 雪印乳業株式会社 高温菌の増殖を抑制できる食品
DE69017921T2 (de) * 1990-01-23 1995-10-12 Morinaga Milk Industry Co Ltd Lactoferrinhydrolysat zur Verwendung als tyrosinagehemmendes Mittel.

Also Published As

Publication number Publication date
DK0474506T3 (da) 1998-06-02
JPH0592994A (ja) 1993-04-16
US5304633A (en) 1994-04-19
CA2050786C (en) 1998-11-10
JP2818056B2 (ja) 1998-10-30
EP0474506B1 (de) 1998-05-13
CA2050786A1 (en) 1992-03-08
AU645342B2 (en) 1994-01-13
DE69129395T2 (de) 1998-12-17
NZ239683A (en) 1993-10-26
AU8370491A (en) 1992-03-12
EP0474506A1 (de) 1992-03-11

Similar Documents

Publication Publication Date Title
DE69129395D1 (de) Antimikrobielle Peptide
DE4393381T1 (de) Peptide
NO942066D0 (no) Peptidderivater
DE69315842T2 (de) Peptidverbindungen
DE69332485T2 (de) Immunmodulierende peptide
FI940945A (fi) Uusia isosteerisiä peptidejä
DK6893D0 (da) Peptid
ATE245162T1 (de) Zyklische peptide mit fungizider wirkung
DK111489D0 (da) Peptider
DK162890D0 (da) Polypeptid
IS4115A (is) Ný peptíð
MX9201416A (es) Peptidos y pseudopeptidos antitromboticos.
ATE225804T1 (de) Zyklische peptide mit fungizider wirkung
FI940109A0 (fi) Peptidejä
NO933097D0 (no) Insektisid virksomme peptider
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
FI934588A (fi) Insulinlik vaextfaktor bindande protein haerstammande fraon maenniskoben
NO932237L (no) Lineaere peptider
NO941950D0 (no) Hemoregulerende peptider
NO177858C (no) Peptid
DK0519976T3 (da) Neutrofilstimulerende peptider
LV10286A (lv) Peptidu savienojumi
FR2732345B1 (fr) Peptide antibacterien
LV10287A (lv) Peptidu savienojumi
DE68914057T2 (de) Peptide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition